Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polio eradication: the OPV paradox.

Walter R Dowdle1, Esther De Gourville, Olen M Kew

  • 1Task Force for Child Survival and Development, Decatur, GA 30030, USA. wdowdle@taskforce.org

Reviews in Medical Virology
|August 22, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Citric acid-enhanced chitosan/hyaluronic acid interpenetrating hydrogel network as a bioinspired adhesive for osteochondral scaffold fabrication.

International journal of biological macromolecules·2026
Same author

Parameter Optimisation in 3D Extrusion Printing of Polyhydroxybutyrate Using Design of Experiment Methodology.

Journal of functional biomaterials·2026
Same author

A larger defect size and more prior surgical procedures are negatively associated with radiological outcome 10 years after tibiofemoral matrix-induced autologous chondrocyte implantation.

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA·2025
Same author

10-Year Clinical and MRI-Based Outcomes of a Randomized Controlled Trial Evaluating a 6-Week Return to Full Weightbearing After Matrix-Induced Autologous Chondrocyte Implantation.

Orthopaedic journal of sports medicine·2025
Same author

Prior procedures, graft location, preoperative physical health, postoperative strength and graft integrity are associated with 10-year clinical outcome after matrix-induced autologous chondrocyte implantation.

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA·2025
Same author

Titanium-Zirconia abutment-implant assemblies: Are they alternatives for single material implants?

Dental materials : official publication of the Academy of Dental Materials·2025

Oral polio vaccine (OPV) has been vital in preventing paralytic poliomyelitis. However, to achieve global polio eradication, OPV use must eventually stop, necessitating careful planning for safe vaccine transition strategies.

Area of Science:

  • * Public Health
  • * Vaccinology
  • * Infectious Disease Epidemiology

Background:

  • * Oral polio vaccine (OPV) has dramatically reduced paralytic poliomyelitis cases since 1961.
  • * OPV's success presents a paradox: it's essential for eradication but also the source of rare vaccine-associated paralytic poliomyelitis (VAPP) and vaccine-derived polioviruses (VDPV).

Purpose of the Study:

  • * To analyze the complexities and risks associated with the eventual discontinuation of OPV.
  • * To explore strategies for transitioning away from OPV post-polio eradication.
  • * To inform the development of safe and effective polio immunization policies for the future.

Main Methods:

  • * Review of polio epidemiology and global eradication progress.
  • * Assessment of risks and benefits associated with OPV and inactivated poliovirus vaccine (IPV).

Related Experiment Videos

  • * Evaluation of surveillance capabilities, vaccine availability, and laboratory containment strategies.

    • Main Results:

    • * Continued OPV use poses a risk of VAPP and VDPV once wild poliovirus is eliminated.
    • * Polio eradication is achievable only through the eventual cessation of OPV immunization.
    • * Transitioning from OPV requires careful consideration of alternative strategies and vaccine development.

    Conclusions:

    • * Safe and scientifically sound strategies are needed to stop OPV use and achieve polio eradication.
    • * Informed post-eradication immunization policies depend on evaluating epidemiology, surveillance, vaccine options, and containment.
    • * The development of a safe and effective replacement for OPV is a key consideration for future polio immunization.